Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond

Cells. 2022 Jul 14;11(14):2198. doi: 10.3390/cells11142198.

Abstract

Respiratory infections with newly emerging zoonotic viruses such as SARS-CoV-2, the etiological agent of COVID-19, often lead to the perturbation of the human innate and adaptive immune responses causing severe disease with high mortality. The responsible mechanisms are commonly virus-specific and often include either over-activated or delayed local interferon responses, which facilitate efficient viral replication in the primary target organ, systemic viral spread, and rapid onset of organ-specific and harmful inflammatory responses. Despite the distinct replication strategies, human infections with SARS-CoV-2 and highly pathogenic avian influenza viruses demonstrate remarkable similarities and differences regarding the mechanisms of immune induction, disease dynamics, as well as the long-term sequelae, which will be discussed in this review. In addition, we will highlight some important lessons about the effectiveness of antiviral and immunomodulatory therapeutic strategies that this pandemic has taught us.

Keywords: COVID-19; highly pathogenic avian influenza; systemic inflammation; viral infection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • Inflammation
  • Pandemics
  • SARS-CoV-2

Substances

  • Antiviral Agents

Grants and funding

This research was funded by the German Research Foundation (DFG) for the Clinical Research Unit CRU342 (for Project P6 granted to L.B: and S.L.), grant number BR 5189/3-1. Furthermore, we are grateful for financial support from the Medical Faculty of the University of Muenster for funding from the Interdisciplinary Centre for Clinical Research (IZKF) (Grant No. Bru2/015/19 to L.B.), and the Innovative Medizinische Forschung (IMF) (Grant No. BR111905 to LB). The work is part of the activities within the Research Alliance VIRAL.NRW of the state of North Rhine Westfalia, Germany, in the research line “immunity against SARS-CoV-2”. J.L. was financially supported by the German Cancer Aid with a Mildred Scheel doctoral thesis scholarship. D.M.Ç. is financially supported through a Study Abroad Program by the Ministry of National Education (Law: 1416), Republic of Turkey.